Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18–70 years of age

Published 2015 View Full Article

Authors

Keywords

Hepatitis B vaccine, Toll-like receptor 9, Age, Sex, BMI, Smokers

Journal

VACCINE

Volume 33, Issue 31, Pages 3614-3618

Publisher

Elsevier BV

Online

2015-06-13

DOI

10.1016/j.vaccine.2015.05.070

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started